Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo

Heme oxygenase-1 (HO-1) can promote tumor growth and reinforce the resistance of diffuse large B-cell lymphoma (DLBCL) cells to chemotherapeutic drug vincristine. We herein found that HO-1 protein expression was higher in high-risk DLBCL patients than in low-risk ones. Silencing HO-1 gene expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhen, Fang, Qin, Ma, Dan, Zhe, Nana, Ren, Mei, Cheng, Bingqing, Li, Peifan, Liu, Ping, Lin, Xiaojing, Tang, Sishi, Hu, Xiuying, Liao, Yudan, Zhang, Yaming, Lu, Tingting, Wang, Jishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667976/
https://www.ncbi.nlm.nih.gov/pubmed/29108243
http://dx.doi.org/10.18632/oncotarget.19652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667976/
https://www.ncbi.nlm.nih.gov/pubmed/29108243
http://dx.doi.org/10.18632/oncotarget.19652

Ejemplares similares